News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
220,744 Results
Type
Article (4977)
Company Profile (22)
Press Release (215745)
Section
Business (82190)
Career Advice (461)
Deals (15037)
Drug Delivery (8)
Drug Development (19052)
Employer Resources (30)
FDA (3673)
Job Trends (3895)
News (120079)
Policy (7496)
Tag
Academia (290)
Alliances (14688)
Alzheimer's disease (212)
Approvals (3667)
Bankruptcy (94)
Best Places to Work (2830)
Biotechnology (24)
Breast cancer (21)
Cancer (201)
Career advice (392)
Cell therapy (44)
Clinical research (15594)
Collaboration (68)
Compensation (58)
COVID-19 (292)
C-suite (31)
Data (216)
Diagnostics (1987)
Earnings (39572)
Employer resources (31)
Events (36768)
Executive appointments (106)
FDA (3765)
Funding (67)
Gene therapy (22)
GLP-1 (94)
Government (404)
Healthcare (4995)
Infectious disease (301)
Inflammatory bowel disease (21)
Interviews (53)
IPO (7725)
Job creations (1119)
Job search strategy (361)
Layoffs (95)
Legal (2321)
Lung cancer (23)
Manufacturing (24)
Medical device (3810)
Medtech (3811)
Mergers & acquisitions (7331)
Metabolic disorders (56)
Neuroscience (249)
NextGen Class of 2024 (1671)
Non-profit (723)
Northern California (420)
Obesity (31)
Opinion (28)
People (24100)
Phase I (4640)
Phase II (6774)
Phase III (5386)
Pipeline (105)
Postmarket research (625)
Preclinical (1820)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (30)
Real estate (1874)
Regulatory (4967)
Research institute (298)
Resumes & cover letters (68)
Southern California (308)
Startups (1005)
United States (3510)
Vaccines (24)
Date
Today (53)
Last 7 days (266)
Last 30 days (795)
Last 365 days (11246)
2024 (9454)
2023 (13196)
2022 (18662)
2021 (19686)
2020 (18249)
2019 (13211)
2018 (10207)
2017 (10010)
2016 (9169)
2015 (12136)
2014 (9596)
2013 (7723)
2012 (8338)
2011 (8808)
2010 (8641)
Location
Africa (182)
Arizona (47)
Asia (11283)
Australia (1548)
California (841)
Canada (407)
China (24)
Colorado (32)
Connecticut (43)
Europe (23937)
Florida (110)
Georgia (18)
Idaho (23)
Illinois (69)
Indiana (33)
Japan (23)
Kansas (23)
Maine (32)
Maryland (114)
Massachusetts (729)
Michigan (55)
Minnesota (95)
Montana (16)
New Jersey (282)
New York (260)
North Carolina (224)
Northern California (420)
Ohio (32)
Pennsylvania (185)
South America (273)
Southern California (308)
Texas (97)
Utah (24)
Washington State (84)
220,744 Results for "hamamatsu corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Indica Labs Receives FDA Clearance for HALO AP Dx Digital Pathology Platform for Use with Hamamatsu Images Acquired with the NanoZoomer® S360MD Slide Scanner
Indica Labs, an industry leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K., a pioneer in whole slide imaging systems, announce that the U.S. Food and Drug Administration (FDA) has issued a 510(k) clearance to Indica Labs for HALO AP Dx, an enterprise digital pathology platform.
May 22, 2024
·
4 min read
Press Releases
Hamamatsu Photonics introduces CYTOQUBE, a new cell analyzer combining light-sheet optics and image analysis in a fast, user-friendly system for 3D cell screening assays
September 9, 2024
·
4 min read
Hamamatsu and Siemens Healthineers announce the distribution of the whole slide scanners to clinical markets
Hamamatsu announced a multi-year distribution agreement with Siemens Healthineers.
March 6, 2023
·
4 min read
Pharm Country
INFINITT announces collaboration with Hamamatsu, a leading manufacturer of whole slide scanners
INFINITT North America announced a collaboration with Hamamatsu Corporation to jointly promote Hamamatsu whole slide scanners and INFINITT Digital Pathology Solution to its United States customers.
September 20, 2022
·
3 min read
Biotech Beach
Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu
Agilent Technologies Inc. announced it has partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range including the S360MD Slide scanner system into the Agilent end-to-end digital pathology solution.
March 10, 2023
·
3 min read
Business
Indica Labs and Hamamatsu Photonics K.K. Announce Collaboration to Provide Optimized Integrated Digital Pathology Workflows
Indica Labs and Hamamatsu Photonics K.K. announced an agreement to maintain long-term interoperability between Indica Lab’s HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.
October 14, 2022
·
5 min read
Business
Proscia and Hamamatsu Announce Collaboration to Accelerate Scaled Adoption of Digital Pathology
Proscia®, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, today announced a collaboration to accelerate digital pathology adoption at an enterprise scale.
March 9, 2022
·
3 min read
Business
Hamamatsu Photonics K.K. and Techcyte Collaborate to Advance Clinical Pathology
Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, is working with Techcyte, a leading provider of a clinical pathology A.I. platform, to advance clinical pathology by improving whole slide imaging of non-histology samples.
December 14, 2021
·
2 min read
Deals
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.
May 28, 2024
·
9 min read
Business
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.
May 13, 2024
·
15 min read
1 of 22,075
Next